Shi‐Ming Lin
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 42
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Hepatitis C virus research 14
- Epidemiology 23
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 11
- Co-authors
- Yun‐Fan Liaw (14 shared papers)Rong‐Nan Chien (4 shared papers)Yun‐Fan Liaw (6 shared papers)I‐Shyan Sheen (19 shared papers)I-Shyan Sheen (2 shared papers)Deng‐Yn Lin (6 shared papers)Chia‐Ming Chu (7 shared papers)Ming‐Lung Yu (3 shared papers)
- Journals
- Liver Cancer (5 papers)Hepatology (5 papers)Journal of Hepatology (4 papers)Journal of Gastroenterology and Hepatology (3 papers)American Journal of Cancer Research (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Shi‐Ming Lin
70 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 88
- Hepatology 1.4k
- Epidemiology 1.2k
- Cancer Research 147
- Oncology 166
- Pathology and Forensic Medicine 96
Countries citing papers authored by Shi‐Ming Lin
This map shows the geographic impact of Shi‐Ming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Ming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Ming Lin more than expected).
Fields of papers citing papers by Shi‐Ming Lin
This network shows the impact of papers produced by Shi‐Ming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Ming Lin. The network helps show where Shi‐Ming Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi‐Ming Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 356 | |
| 2 | 2006 | 246 | |
| 3 | 1997 | 143 | |
| 4 | 2003 | 126 | |
| 5 | 1992 | 107 | |
| 6 | 2004 | 106 | |
| 7 | 2005 | 92 | |
| 8 | 2006 | 91 | |
| 9 | 2018 | 67 | |
| 10 | 1994 | 60 | |
| 11 | 1991 | 60 | |
| 12 | 2007 | 57 | |
| 13 | 2015 | 41 | |
| 14 | 2006 | 40 | |
| 15 | 2014 | 39 | |
| 16 | 2008 | 36 | |
| 17 | 2014 | 35 | |
| 18 | 1993 | 31 | |
| 19 | Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma. | 2010 | 27 |
| 20 | 1999 | 27 |
About Shi‐Ming Lin
Shi‐Ming Lin is a scholar working on Hepatology, Epidemiology, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (11 papers), Renal cell carcinoma treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (1.2k citations), Cancer Research (147 citations), Oncology (166 citations) and Pathology and Forensic Medicine (96 citations). Shi‐Ming Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yun‐Fan Liaw, Rong‐Nan Chien, Yun‐Fan Liaw, I‐Shyan Sheen, I-Shyan Sheen, Deng‐Yn Lin, Chia‐Ming Chu, Ming‐Lung Yu, Chuan–Mo Lee and Ming‐Whei Yu. Their work appears in journals such as Liver Cancer, Hepatology, Journal of Hepatology, Journal of Gastroenterology and Hepatology and American Journal of Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.